Literature DB >> 18067496

A touch of TRALI.

Amanda Davis1, Rajni Mandal, Matthew Johnson, Robert Makar, Christopher Stowell, Sunny Dzik.   

Abstract

Transfusion-related acute lung injury (TRALI) is a leading cause of transfusion-associated morbidity and mortality. The National Heart, Lung, and Blood Institute (NHLBI) and Canadian Consensus Conference definitions of TRALI exclude cases of mild TRALI. As a result, many cases of mild TRALI are likely to be missed. Three cases are reported in which patients experienced the acute onset of breathlessness in association with transfusion of blood components containing human leukocyte antigen (HLA) antibodies reactive with recipient HLA antigens. Despite the sudden onset of a pulmonary syndrome in association with transfusion, clinicians caring for these patients did not consider TRALI, and no case would meet recent consensus definitions. Nevertheless, supporting clinical and serologic evidence for TRALI was found in each case. Benefits in recognizing mild cases of TRALI include quantifying the true incidence of TRALI, understanding the physiology of mild versus severe TRALI, and preventing subsequent cases of TRALI due to donors found to have HLA antibodies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18067496     DOI: 10.1111/j.1537-2995.2007.01567.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  8 in total

1.  Swiss Haemovigilance Data and Implementation of Measures for the Prevention of Transfusion Associated Acute Lung Injury (TRALI).

Authors:  Markus Jutzi; Guy Levy; Behrouz Mansouri Taleghani
Journal:  Transfus Med Hemother       Date:  2008-03-17       Impact factor: 3.747

2.  Long-term survival and quality of life after transfusion-associated pulmonary edema in critically ill medical patients.

Authors:  Guangxi Li; Marija Kojicic; Martin K Reriani; Evans R Fernández Pérez; Lokendra Thakur; Rahul Kashyap; Camille M Van Buskirk; Ognjen Gajic
Journal:  Chest       Date:  2009-10-16       Impact factor: 9.410

Review 3.  Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality.

Authors:  Eleftherios C Vamvakas; Morris A Blajchman
Journal:  Transfus Med Rev       Date:  2010-04

4.  Acute non-hemolytic transfusion reactions and HLA class I antibody: advantages of solid phase assay compared with conventional complement-dependent assay.

Authors:  S Imoto; K Kawamura; Y Tokumine; N Araki; S Akita; C Nishimura; H Inaba; K Saigo; O Mabuchi; H Okazaki
Journal:  Transfus Med       Date:  2009-10-30       Impact factor: 2.019

Review 5.  [Coagulation management in multiple trauma].

Authors:  C Waydhas; K Görlinger
Journal:  Unfallchirurg       Date:  2009-11       Impact factor: 1.000

Review 6.  [Risks and side effects of blood transfusion].

Authors:  B Fölsch; U Cassens
Journal:  Orthopade       Date:  2009-09-06       Impact factor: 1.087

Review 7.  Risk factors, management and prevention of transfusion-related acute lung injury: a comprehensive update.

Authors:  Susan A Kuldanek; Marguerite Kelher; Christopher C Silliman
Journal:  Expert Rev Hematol       Date:  2019-07-16       Impact factor: 2.929

8.  A consensus redefinition of transfusion-related acute lung injury.

Authors:  Alexander P J Vlaar; Pearl Toy; Mark Fung; Mark R Looney; Nicole P Juffermans; Juergen Bux; Paula Bolton-Maggs; Anna L Peters; Christopher C Silliman; Daryl J Kor; Steve Kleinman
Journal:  Transfusion       Date:  2019-04-16       Impact factor: 3.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.